Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yugo Okazaki"'
Autor:
Naoki Okumura, Yugo Okazaki, Noriko Koizumi, Kazuhiko Mori, Daiki Matsumoto, Shigeru Kinoshita, Chie Sotozono
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 256:751-757
This study investigates the possible role of the filtration bleb in the continuous decrease in corneal endothelial cell (CEC) density observed following trabeculectomy. This study involved 51 eyes of 37 glaucoma patients who underwent trabeculectomy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bd218376030cbce8b416dcd29a775c3
https://doi.org/10.1007/s00417-017-3889-1
https://doi.org/10.1007/s00417-017-3889-1
Autor:
Ayaka Kusakabe, Hiroatsu Hirano, Shigeru Kinoshita, Yugo Okazaki, Ryota Inoue, Shinichiro Nakano, Naoki Okumura, Noriko Koizumi
Publikováno v:
Scientific Reports
The corneal endothelium is essential for maintaining corneal transparency; therefore, corneal endothelial dysfunction causes serious vision loss. Tissue engineering-based therapy is potentially a less invasive and more effective therapeutic modality.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc3e7f5cb3ccf5464321b3b220cba97
https://doi.org/10.1038/srep15005
https://doi.org/10.1038/srep15005
Autor:
Naoki Okumura, Shigeru Kinoshita, Hiroko Nakagawa, Yugo Okazaki, Ryota Inoue, Noriko Koizumi, Shinichiro Nakano
Publikováno v:
Investigative ophthalmologyvisual science. 56(10)
PURPOSE The purpose of this study was to investigate the feasibility of using Rho-associated kinase (ROCK) inhibitor eye drops for treating severe corneal endothelial damage due to surgical invasion. METHODS A rabbit corneal endothelial damage model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f3d6cf6dc6bdf7a8058f134ccaeee6
https://pubmed.ncbi.nlm.nih.gov/26393474
https://pubmed.ncbi.nlm.nih.gov/26393474
Autor:
Nigel J. Fullwood, Elena Koudouna, Ryota Inoue, Yugo Okazaki, Shinichiro Nakano, Naoki Okumura, Noriko Koizumi, Shigeru Kinoshita, Junko Hori
Publikováno v:
Investigative Opthalmology & Visual Science. 58:242
Purpose: Corneal endothelial cell density undergoes a progressive decrease for many years after transplantation, eventually threatening patients with late endothelial failure. The purpose of this study was to investigate the possibility of an immunol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df5c6a564eb5469be5807ddf7ab09396
https://doi.org/10.1167/iovs.16-20019
https://doi.org/10.1167/iovs.16-20019
Autor:
Noriko Koizumi, Naoki Okumura, Ryota Inoue, Shigeru Kinoshita, Shinichiro Nakano, Kazuya Kakutani, Yugo Okazaki
Publikováno v:
Investigative Opthalmology & Visual Science. 57:1284
PURPOSE Ripasudil (Glanatec), a selective rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved as a glaucoma and ocular hypertension treatment in Japan in 2014. The purpose of this study was to investigate the feasibili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108635ccb8886460a3298a4394fffdbf
https://doi.org/10.1167/iovs.15-18586
https://doi.org/10.1167/iovs.15-18586
Autor:
Ryota Inoue, Nigel J. Fullwood, Noriko Koizumi, Shinichiro Nakano, Yugo Okazaki, Naoki Okumura, Shigeru Kinoshita
Publikováno v:
Investigative Opthalmology & Visual Science. 56:7560
PURPOSE: Ripasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the treatment of glaucoma and ocular hypertension. The purpose of this study was to investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a2a4cd46f3c2483a19dc451aa1cd860
https://doi.org/10.1167/iovs.15-17887
https://doi.org/10.1167/iovs.15-17887
Autor:
Naoki Okumura, Ayaka Kusakabe, Hiroatsu Hirano, Ryota Inoue, Yugo Okazaki, Shinichiro Nakano, Shigeru Kinoshita, Noriko Koizumi
Publikováno v:
Scientific Reports; 10/9/2015, p1-11, 11p